Trump Orders 100 % Tariff Threat on Patented Drug Imports and Resets Metal Duties
On 2 April 2026, President Trump invoked Section 232 to impose a tariff ladder that rises to 100 % on patented drug imports from companies without U.S. price-cut/onshoring deals and re-defined his existing 50 % metal tariffs to capture the full customs value of products.